| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |